Israel Englander Trillium Therapeutics Inc. Transaction History

Millennium Management LLC

  • $192 Billion
  • Q2 2025

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-553,684 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
345,612 Added 166.1%
553,684 $9.73 Million
Q2 2021

Aug 16, 2021
SELL
N/A
-572,686 Reduced 73.35%
208,072 $2.02 Million
Q1 2021

May 17, 2021
SELL
N/A
-90,566 Reduced 10.39%
780,758 $8.39 Million
Q4 2020

Feb 16, 2021
BUY
N/A
266,867 Added 44.15%
871,324 $12.8 Million
Q3 2020

Nov 16, 2020
SELL
N/A
-44,396 Reduced 6.84%
604,457 $8.59 Million
Q2 2020

Aug 14, 2020
SELL
N/A
-1,094,677 Reduced 62.79%
648,853 $5.25 Million
Q1 2020

May 14, 2020
BUY
N/A
1,743,530 New
1,743,530 $7.04 Million
Q3 2018

Nov 14, 2018
SELL
N/A
-13,704 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
N/A
-2,822 Reduced 17.08%
13,704 $82,000
Q1 2018

May 15, 2018
BUY
N/A
3,926 Added 31.16%
16,526 $119,000
Q4 2017

Feb 14, 2018
BUY
N/A
782 Added 6.62%
12,600 $91,000
Q3 2017

Nov 14, 2017
BUY
N/A
11,818
11,818 $61,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email